Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00186355
Status:
COMPLETED
Last Update Posted:
2012-05-14
First Post:
2005-09-13
Brief Title:
Enrichment Purging of Stem Cells in Non-Hodgkins Lymphoma
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Enrichment and Purging of Stem Cells in the Treatment of Non-Hodgkins Lymphoma
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the role of purging the hematopoietic cell graft on outcomes for non-Hodgkins Lymphoma
Detailed Description:
To study the use of peripheral blood stem cells which have been treated in an effort to remove tumor cells The researchers hope to learn whether or not this will be more effective in removing the tumor cells as compared to other methods of purging the removal of cancer cells
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 12170 | OTHER | Stanford IRB | None |
| 77063 | OTHER | None | None |
| NCT00186355 | None | None | None |